BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fluoxetine
,
rs3825942
,
SLC12A1
,
Response to oxidative stress
,
Diabetes mellitus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
clpP
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Plasma cell of spleen
Skeletal muscle
T Lymphocyte (CD8+) of peripheral blood
Extraocular muscle
Jejunum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Structural insights into the evolutionary simplification of human ClpP activators.
Substrates and interactors of the ClpP protease in the mitochondria.
Assessment of the structure-activity relationship and antileukemic activity of diacylpyramide compou…
CLPP deficiency ameliorates neurodegeneration caused by impaired mitochondrial protein synthesis.
New Global Insights on the Regulation of the Biphasic Life Cycle and Virulence Via ClpP-Dependent Pr…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
ONC206 for Treatment of Newly Diagnosed, or Recurrent Diffuse Midline Gliomas, and Other Recurrent M…
Heat Therapy to Prevent Deconditioning During Immobilization
Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas
Combination Therapy for the Treatment of Diffuse Midline Gliomas
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ